RBC Capital on AdaptHealth (AHCO): 'Shares Appear Oversold Following Solid Guidance'
Tweet Send to a Friend
RBC Capital analyst Ben Hendrix reiterated an Outperform rating and $13.00 price target on AdaptHealth (NASDAQ: AHCO).The analyst commented: "Shares ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
